About Kritika Sarmah

Her interest in risky instruments and passion for writing made Kritika an analyst and financial journalist. She earned her bachelor's degree in commerce and is currently pursuing the CFA program. With her fundamental approach, she aims to help investors identify untapped investment opportunities.


Recent Articles By Kritika Sarmah

: CRM |  News, Ratings, and Charts

3 Tech Stocks to Watch Closely in 2023

Despite macroeconomic challenges, the tech industry is using digital advancements to support innovation and transformation across sectors, which is expected to boost its growth. Therefore, fundamentally strong tech stocks Salesforce (CRM), Juniper Networks (JNPR), and AudioCodes (AUDC) might be ideal additions to your watchlists. Read on...
: GM |  News, Ratings, and Charts

1 Unstoppable Stock to Buy in March 2023

US’ top automaker, General Motors (GM), reported solid fourth-quarter and fiscal year 2022 results. Moreover, the company intends to capitalize on the craze for EVs and is actively collaborating with other companies to drive more customers and sales. Given its sound fundamentals, the stock might be an ideal buy. Read more...
: MCD |  News, Ratings, and Charts

1 Large-Cap Stock to Buy at a Discount Right Now

The popular restaurant operator McDonald's (MCD) announced fourth-quarter results that surpassed expectations, despite the unfavorable macroeconomic conditions. However, with the increased market instability, the stock has declined over the past few months and seems to be trading at a discount. This could be the right opportunity to invest in this large-cap stock. Keep reading...
: KO |  News, Ratings, and Charts

2 Beverage Stocks to Hold for the Next 20 Years

The beverage industry is growing amid changing preferences and the growing spending power of consumers. Moreover, as consumers are becoming health conscious and are rapidly shifting to non-alcoholic beverages, fundamentally sound Coca-Cola (KO) and Primo Water (PRMW) might be ideal buys for the long term. These stocks pay reliable dividends. Keep reading...
: PLTK |  News, Ratings, and Charts

1 Gaming Stock to Buy in 2023 and 1 to Sell

The gaming industry is growing amid the increasing use of smartphones and the adoption of advanced technologies. However, the lingering macroeconomic headwinds could limit its near-term growth. Therefore, while we think fundamentally strong gaming stock Playtika Holding (PLTK) might be worth buying now, Roblox (RBLX) could be best avoided. Read on...
: LLY |  News, Ratings, and Charts

5 Best Pharma Stocks to Buy Right Now

The pharma industry has experienced tremendous growth in recent years and should continue to grow amid the integration of advanced technologies. Hence, pharma stocks Eli Lilly (LLY), Takeda Pharmaceutical (TAK), Catalyst Pharmaceuticals (CPRX), Poseida Therapeutics (PSTX), and Voyager Therapeutics (VYGR) might be worth buying right now. Read on...
: BMY |  News, Ratings, and Charts

2 Dividend Stocks That Could Pay You for the Rest of Your Life

As the market remains volatile due to ongoing concerns about elevated inflation, prolonged rate hikes, and an impending recession, fundamentally strong dividend stocks Bristol-Myers Squibb (BMY) Gilead Sciences (GILD) might be ideal buys to ensure a stable income stream. Moreover, these stocks could be great long-term investments. Read more...
: GM |  News, Ratings, and Charts

2 Hot Stocks You Don't Want to Miss

While the Fed’s aggressive policy has impacted demand, the auto industry is expected to witness a recovery this year. Hence, fundamentally strong auto parts stocks General Motors (GM) and Honda Motor (HMC) might be solid buys now. Keep reading...
: PFE |  News, Ratings, and Charts

4 Stocks to Buy in Any Market Climate

The stock market is expected to remain volatile in the near term as investors remain anxious about the Fed’s actions. Amid high recession worries, fundamentally strong healthcare stocks, Pfizer (PFE), Bristol-Myers Squibb (BMY), Amgen (AMGN), and Elevance Health (ELV), which have the potential to withstand any market downturns, could be ideal investments now. Read more...
: ABT |  News, Ratings, and Charts

3 Health Care Stocks to Buy in a Heartbeat

The healthcare industry is expanding, fueled by the increasing demand and advancements such as personalized medicines and telehealth. Hence, fundamentally strong healthcare stocks Abbott Laboratories (ABT), Centene (CNC), and McKesson (MCK) might be worth buying in 2023. Read more...
Page generated in 1.2759 seconds.